サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1636054

ゴーシェ病市場：タイプ別、診断・治療別、エンドユーザー別、地域別、2025-2033年

Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 127 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ゴーシェ病市場：タイプ別、診断・治療別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 127 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ゴーシェ病市場の世界市場規模は2024年に18億米ドルに達しました。IMARC Groupは、2025年から2033年にかけての成長率（CAGR）は6％で、2033年には30億米ドルに達すると予測しています。ゴーシェ病患者の増加、広範な研究開発活動、薬剤の入手しやすさなどが市場を牽引する主な要因です。

ゴーシェ病は、ライソゾーム貯蔵障害としても知られ、体内の脂肪を分解・貯蔵する能力に影響を及ぼす稀な遺伝性代謝疾患です。体内のグルコセレブロシド脂肪化学物質を分解するグルコセレブロシダーゼの欠損によって引き起こされます。脾臓や肝臓の肥大、貧血、あざができやすく出血しやすい、肺障害、疲労、発作、骨の異常などを伴う。様々な身体検査、病歴、血液検査や画像検査などの臨床検査、遺伝子の変異の有無を確認する遺伝子検査によって診断されます。ゴーシェ病の治療には、薬物療法、注射療法、酵素補充療法（ERT）、骨髄移植、基質除去療法（SRT）などがあり、症状に伴う痛みを最小限に抑え、生活の質を向上させる効果があります。

ゴーシェ病市場動向：

現在、個人の間で遺伝子異常の有病率が増加し、ゴーシェ病患者の数が増加していることは、世界中で市場の成長を後押しする主な要因の一つです。さらに、これらの医学的障害を発症しやすい高齢化人口の増加が、ゴーシェ病治療に対する需要の増加をもたらしています。加えて、ゴーシェ病治療のための経済的支援を提供し、医療費を削減する健康保険の導入が増加しています。これとは別に、ゴーシェ病、その症状、診断、治療オプションの容易な利用可能性に関する意識の高まりが、市場にプラスの影響を与えています。さらに、多くの国々の政府は、ゴーシェ病の研究と新しい治療法を開発するための研究開発（R&D）活動に投資しています。また、誰もが利用しやすい質の高いヘルスケア施設を提供するための対策にも取り組んでいます。このことは、診断技術の著しい向上と相まって、市場に明るい見通しをもたらしています。これに加えて、グルコセレブロシドを分解して蓄積を減少させる経口療法のようなERT治療代替薬が容易に入手可能であるという認識が高まっていることも、市場の成長に寄与しています。一般に、ゴーシェ病に伴う痛みを和らげるために、市販薬（OTC）や処方箋で容易に入手できるジェネリック医薬品が使用されています。

本レポートで扱う主な質問

  • 世界のゴーシェ病市場の市場規模は？
  • 2025-2033年における世界のゴーシェ病市場の予想成長率は？
  • 世界のゴーシェ病市場を牽引する主要因は何か？
  • 世界のゴーシェ病市場に対するCOVID-19の影響は？
  • 世界のゴーシェ病市場のタイプ別内訳は？
  • ゴーシェ病市場の世界における主要地域は？
  • 世界のゴーシェ病市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のゴーシェ病市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • ゴーシェ病1型
    • 市場動向
    • 市場予測
  • ゴーシェ病2型
    • 市場動向
    • 市場予測
  • ゴーシェ病3型
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：診断・治療別

  • 診断
    • 市場動向
    • 主要セグメント
      • 身体検査
      • 血液検査
      • 画像検査
      • 妊娠前スクリーニングと出生前検査
      • その他
    • 市場予測
  • 治療
    • 市場動向
    • 主要セグメント
      • 手術
      • 投薬
      • その他
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 専門クリニック
    • 市場動向
    • 市場予測
  • 在宅ケア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • ISU Abxis Co. Ltd.
    • Johnson & Johnson
    • Pfizer Inc.
    • Protalix Biotherapeutics
    • Sanofi S.A
    • Takeda Pharmaceutical Company Limited
図表

List of Figures

  • Figure 1: Global: Gaucher Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Gaucher Disease Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Gaucher Disease Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Gaucher Disease Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Gaucher Disease Market: Breakup by Diagnosis and Treatment (in %), 2024
  • Figure 6: Global: Gaucher Disease Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Gaucher Disease Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Gaucher Disease (Gaucher Disease Type 1) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Gaucher Disease (Gaucher Disease Type 1) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Gaucher Disease (Gaucher Disease Type 2) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Gaucher Disease (Gaucher Disease Type 2) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Gaucher Disease (Gaucher Disease Type 3) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Gaucher Disease (Gaucher Disease Type 3) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Gaucher Disease (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Gaucher Disease (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Gaucher Disease (Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Gaucher Disease (Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Gaucher Disease (Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Gaucher Disease (Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Gaucher Disease (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Gaucher Disease (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Gaucher Disease (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Gaucher Disease (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Gaucher Disease (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Gaucher Disease (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Gaucher Disease (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Gaucher Disease (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Gaucher Disease Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Gaucher Disease Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Gaucher Disease Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Gaucher Disease Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Gaucher Disease Industry: Value Chain Analysis
  • Figure 79: Global: Gaucher Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gaucher Disease Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Gaucher Disease Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Gaucher Disease Market Forecast: Breakup by Diagnosis and Treatment (in Million USD), 2025-2033
  • Table 4: Global: Gaucher Disease Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Gaucher Disease Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Gaucher Disease Market: Competitive Structure
  • Table 7: Global: Gaucher Disease Market: Key Players
目次
Product Code: SR112025A6807

The global Gaucher disease market size reached USD 1.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6% during 2025-2033. Increasing number of patients suffering from Gaucher disease, extensive research and development (R&D) activities, and the easy availability of drugs represent some of the key factors driving the market.

Gaucher disease, also known as lysosomal storage disorder, is a rare genetic metabolic disorder that affects the ability of the body to break down and store fats. It is caused by glucocerebrosidase deficiency, which breaks down glucocerebroside fatty chemicals in the body. It is associated with an enlarged spleen and liver, anemia, easy bruising and bleeding, lung problems, fatigue, seizures, and bone abnormalities. It is diagnosed through various physical examinations, medical history, and laboratory tests, such as blood and imaging tests, and genetic testing to confirm the presence of a mutation in the gene. Gaucher disease can be treated using medications, injections, enzyme replacement therapy (ERT), bone marrow transplantation, and substrate reduction therapy (SRT), which aid in minimizing the pain associated with the symptoms and improve the quality of life.

Gaucher Disease Market Trends:

At present, the increasing prevalence of genetic abnormalities among individuals and the rising number of patients suffering from Gaucher disease represent one of the major factors bolstering the market growth around the world. Moreover, the growing aging population that is more prone to developing these medical disorders is resulting in an increasing demand for Gaucher disease treatment. In addition, there is a rise in the implementation of health insurance policies that provide financial assistance for Gaucher disease treatment and reduce medical expenses. Apart from this, the growing awareness about Gaucher disease, its symptoms, diagnosis, and the easy availability of the treatment options is influencing the market positively. Furthermore, governments of numerous countries are investing in research and development (R&D) activities to study Gaucher disease and develop new treatments. They are also undertaking measures to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is creating a positive outlook for the market. Besides this, the rising awareness about the easy availability of ERT treatment alternatives like oral therapies that help break down glucocerebroside and reduce the accumulation is contributing to the growth of the market. They generally involve generic drugs that are readily available over the counter (OTC) and by prescription for relieving pain associated with Gaucher disease.

Key Market Segmentation:

Type Insights:

  • Gaucher Disease Type 1
  • Gaucher Disease Type 2
  • Gaucher Disease Type 3
  • Others

Diagnosis and Treatment Insights:

  • Diagnosis
  • Physical Exam
  • Blood Tests
  • Imaging Tests
  • Preconception Screening and Prenatal Testing
  • Others
  • Treatment
  • Surgery
  • Medication
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Gaucher disease. Some of the factors driving the North America Gaucher disease market included increasing prevalence of genetic abnormalities, the presence of a well-established healthcare infrastructure, the integration of advanced medical technologies, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global Gaucher disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include ISU Abxis Co. Ltd., Johnson & Johnson, Pfizer Inc., Protalix Biotherapeutics, Sanofi S.A, Takeda Pharmaceutical Company Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global Gaucher disease market?
  • 2. What is the expected growth rate of the global Gaucher disease market during 2025-2033?
  • 3. What are the key factors driving the global Gaucher disease market?
  • 4. What has been the impact of COVID-19 on the global Gaucher disease market?
  • 5. What is the breakup of the global Gaucher disease market based on the type?
  • 6. What are the key regions in the global Gaucher disease market?
  • 7. Who are the key players/companies in the global Gaucher disease market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gaucher Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gaucher Disease Type 1
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Gaucher Disease Type 2
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gaucher Disease Type 3
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Diagnosis and Treatment

  • 7.1 Diagnosis
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Physical Exam
      • 7.1.2.2 Blood Tests
      • 7.1.2.3 Imaging Tests
      • 7.1.2.4 Preconception Screening and Prenatal Testing
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Surgery
      • 7.2.2.2 Medication
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Homecare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ISU Abxis Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Pfizer Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Protalix Biotherapeutics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Sanofi S.A
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Takeda Pharmaceutical Company Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.